USPTO serial 77560268
TURMERIC POWER
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- AYALA, LOURDES
- Law office
- OFFICE OF TRADEMARK PROGRAM CONTROL
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TURMERIC POWER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer L. Whitelaw
JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRL N FL 3NAPLES, FL 34103-3590UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Botanical herbal extracts for use in making cosmetics; botanical extracts for use in the manufacture of nutraceuticals and pharmaceuticals; chemical extracts and active principles extracted from medicinal plants for use in the manufacture of nutraceuticals and pharmaceuticals, namely, chemical agents made from botanical extracts; chemical extracts and active principles extracted from medicinal plants for use in the pharmaceutical industry, namely, chemical agents made from botanical extracts or association of chemical extracts for use in the manufacture of pharmaceutical or nutraceutical products; botanical extracts for use in the manufacture of medicated preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanical extracts used in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, algal extracts and algal extract blends, all for use in the manufacture of nutritional supplements and vitamins; algal extracts or algal extract blends for use in the manufacture of nutritional and dietary supplements; mushroom, fungus, and spore extracts for use in food manufacture, all listed products containing turmeric | ABANDONED | — |
| 003 | Herbal products, namely, aromatherapy packs filled with herbs for use in aromatherapy; pre-moistened non-medicated personal hygiene wipes impregnated with cleansing compounds, namely, herpes relief wipes; essential oils featuring herbal extracts, algal extracts and algal extract blends for cosmetic purposes; fragrances; fragrances for personal use; food flavorings prepared from essential oils, all listed products containing turmeric | ABANDONED | — |
| 005 | Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; herbal extracts and blends used as an integral ingredient in medicinal foods or beverages; botanical extracts and blends used as an integral ingredient in medicinal foods or beverages; nutritional supplements; herbal products, namely, medicated skin and lip balms; medicated herbal products, namely, ointments, oils, drinks, infusions, syrups, herbal extracts, poisons, tinctures for medical use in the treatment of strokes, infarcts and other cardiovascular and cerebrum diseases; herbal products, namely, mentholated ointments for medical use; oils, namely, fish extract oils for nutritional purposes, nutritional oils not for cosmetic purposes, vitamin oils for human consumption; drinks, namely, meal replacement drinks; dietary supplement drinks, medicinal drinks, and fish oil for use as a dietary supplement and as a nutraceutical dietary supplement; syrups, namely, cough syrups; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; herbal products for medicinal purposes, namely, herbal extracts and syrups; medicinal herb extracts; medicinal herb extracts for medical purposes; plant extracts for medical, nutritional, pharmaceutical and/or veterinary purposes; medicinal herb extracts used in preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; medicinal herbal extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection; botanical extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, tincture, suppositories and ampule for injection used to treat skin ailments, for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; yeast extracts for medical, nutraceutical or pharmaceutical purposes; herbal products, namely, herbal powders for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; herbal products, namely, herbal powders sold as an integral ingredient of nutritional supplement drink mixes for nutritional purposes; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; pharmaceutical preparations, namely, appetite suppressants and lipid lowering agents; food for diabetics, infants and enteral feeding; botanical extracts for nutritional use; botanical extracts for nutraceuticals, nutritional use, and pharmaceuticals; botanical extracts for medical, veterinary, nutraceutical and pharmaceutical purposes; designer extracts, namely, herbal extracts for medical, veterinary and pharmaceutical purposes; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, all sold as components of nutritional supplements and vitamins; nutritional oils not for cosmetic purposes; food supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; food supplements, namely, anti-oxidants; food for medically restricted diets; dietary supplements, namely, vitamins and mineral supplements; anti-cough drops; cough drops; cough expectorants; throat lozenges; cough lozenges; cough syrups; cough treatment preparations; cold sore treatment preparations; pharmaceutical antitussive-cold preparations; preparations for treating colds; analgesic preparations; analgesics; antipyretic analgesics; ibuprofen for use as an oral analgesic; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; pharmaceutical preparations for the treatment and prevention of herpes; vaccines for the treatment and prevention of herpes; medical biological preparations for the treatment and prevention of herpes; pharmaceutical preparations for the treatment of herpes simplex infection; pharmaceutical capsules for the treatment of herpes simplex infection; homeopathic preparations for the treatment of herpes and cold sores; pharmaceutical preparations for the treatment of herpes viruses; medicated topical clear fluoride gel for the treatment of herpes virus during the physical manifestation of the virus; pharmaceutical preparations for the treatment of herpes simplex virus type I or type ii or herpes zoster virus, not in intravenous form; plant based antivirals; over-the-counter topical antivirals; pharmaceutical preparation with antiviral and/or antimicrobial properties for use in the treatment of herpetic keratitis, conjunctivitis, hiv retinopathy, viral influenza "flu", herpes simplex virus 1, herpes simplex virus 2, varicella zoster virus "herpes zoster" "shingles", cytomegalovirus, viral parainfluenza, adenovirus, viral encephalitis, viral meningitis, arbovirus, arenavirus, picornavirus, coronavirus, syntialvirus, viral infections, common colds caused by viruses, cold sores, human immunedeficiency virus "hiv", roseola infantum, human herpes iv; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes; pharmaceutical preparations for treating immune diseases induced by virus, namely, herpes, herpes zoster and aids; functional foods, namely, dietetic foods adapted for medical purposes, food for diabetics, infants and enteral feeding, food for medically restricted diets; functional beverages, namely, nutritionally fortified beverages; medicinal foods, namely, processed food for medical purposes; animal health products, namely, animal feed supplements, medicated animal feed, micro-nutrient animal feed, dietary supplements for animals, non-medicated additives for animal feed for use as nutritional supplements, nutritional drinks for animals, pharmaceutical preparations for animal skincare; botanical extracts for medical, veterinary and pharmaceutical purposes; herbal extracts for medical, veterinary and pharmaceutical purposes; designer extracts, namely, plant, herbal and botanical extracts for medical, veterinary and pharmaceutical purposes; biodefense products, namely, medicinal preparations for the treatment of infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; nutritionally fortified beverages for immune enhancement; nutritionally fortified beverages with rice bran and wheat bran; algal products for medicinal purposes, namely, algal extracts or algal extract blends for use as nutritional and dietary supplements; algal products, namely, algal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; algal products, namely, algal powders for nutritional purposes; algal extracts or algal extract blends for medical or pharmaceutical purposes, all listed products containing turmeric | ABANDONED | — |
| 029 | Food beverages, namely, dairy-based food beverages, fruit-based food beverages, vegetable-based food beverages, dairy-based chocolate food beverages, soy-based food beverage used as a milk substitute, vegetable-based chocolate food beverages and peanut-based food beverages; milk beverages, namely, milk, milk beverages containing fruits, milk beverages with high milk content, milk based beverages containing fruit juice and milk beverages containing coffee; milk powder; milk powder for nutritional purposes; powdered milk for food purposes; functional foods, namely, dairy-based food beverages, fruit-based food beverages, vegetable-based food beverages, dairy-based chocolate food beverages, soy-based food beverage used as a milk substitute, vegetable-based chocolate food beverages, nut-based food beverages, milk, milk beverages containing fruits, milk beverages with high milk content, milk based beverages containing fruit juice, and milk beverages containing coffee; soy protein for use as a food additive, all listed products containing turmeric | ABANDONED | — |
| 030 | Herbal food beverages; processed herbs; organic foods, namely, chocolate, dairy-free chocolate, reduced fat chocolate, reduced calorie chocolate, cocoa, chocolate chips, chocolate fondue, chocolate toppings, reduced fat candy, bakery products, namely, cookies, cakes, pies and muffins, crackers, biscuits, ready-to-eat cereal-derived food bars, pretzels, chewing gum, frozen yogurt, frozen custard, fruit ices, pancake, waffle and bread mixes, salad dressing, pasta and pasta mixes, rice, cornmeal and wheat based snack foods; food beverages, namely, chocolate food beverages not being dairy-based or vegetable based, herbal food beverages, and grain-based food beverages; functional foods, namely, chocolate, dairy-free chocolate, reduced fat chocolate, reduced calorie chocolate, cocoa, chocolate chips, chocolate fondue, chocolate toppings, reduced fat candy, bakery products, namely, cookies, cakes, pies and muffins, crackers, biscuits, ready-to-eat cereal-derived food bars, pretzels, chewing gum, frozen yogurt, frozen custard, fruit ices, pancake, waffle and bread mixes, salad dressing, pasta and packaged meal mixes consisting primarily of pasta, rice, cornmeal and wheat based snack foods, bread, breakfast cereals; functional beverages, namely, grain based food beverages containing oats or oat extracts, herbal food beverages; food beverages, namely, chocolate food beverages not being dairy-based or vegetable based, herbal food beverages, and grain-based food beverages; food flavorings; herbal extracts and blends for use as component ingredients in functional foods or beverages; botanical extracts and blends for use as component ingredients in functional foods or beverages; herbal infusions; omega and fish oil extracts used as flavorings; processed wheat bran; stabilized rice bran; wheat bran and rice bran based snack foods, all listed products containing turmeric | ABANDONED | — |
| 032 | Organic beverages, namely, fruit drinks, soft drinks, drinking water and fruit and vegetable juices; functional beverages, namely, fruit drinks, soft drinks, drinking water and fruit and vegetable juices, all listed products containing turmeric | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HerbalScience Group, LLC
- Other trademarks owned by HerbalScience Group, LLC
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 030
- Other trademarks in Class 032
- Similar marks named TURMERIC POWER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2010 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Jun 11, 2010 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| May 27, 2010 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Dec 29, 2009 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 1, 2009 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 1, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 28, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 28, 2009 | ALIE | ASSIGNED TO LIE | — |
| Oct 19, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 19, 2009 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 19, 2009 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Oct 8, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 7, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 7, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 25, 2009 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 25, 2009 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 25, 2009 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 23, 2009 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 15, 2009 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 29, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 21, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 21, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 19, 2009 | ZZAX | PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU | — |
| May 16, 2009 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 6, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 30, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2009 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 13, 2009 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 13, 2009 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 13, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 10, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 10, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 10, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 10, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 23, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 20, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 23, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 5, 2008 | NWAP | NEW APPLICATION ENTERED | — |